The reported statements, read against the company's own industry.
Financials view
Market Capitalization
266.07MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue (TTM)
66.73MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Profit Margin
-41.65%
Updated Jul 19, 2026
Beta
0.3940x
vs all stocks
Updated Jul 19, 2026
52-Week Change
97.02%
vs all stocks
Updated Jul 19, 2026
Market Capitalization
266.07MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Enterprise Value
253.84MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Forward P/E
28.70x
Updated Jul 19, 2026
Price to Sales (TTM)
3.99x
Updated Jul 19, 2026
Price to Book (MRQ)
3.34x
Updated Jul 19, 2026
Enterprise to Revenue
3.80x
Updated Jul 19, 2026
Enterprise to EBITDA
-11.82x
Updated Jul 19, 2026
Gross Margin
86.39%
Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 80.47%.Updated Jul 19, 2026
Profit Margin
-41.65%
Updated Jul 19, 2026
Operating Margin
-23.58%
Updated Jul 19, 2026
Return on Assets (TTM)
-12.91%
Updated Jul 19, 2026
Return on Equity (TTM)
-34.67%
Updated Jul 19, 2026
Revenue (TTM)
66.73MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Revenue per Share (TTM)
2.19USDUpdated Jul 19, 2026
Quarterly Revenue Growth
26.00%
Updated Jul 19, 2026
Gross Profit (TTM)
53.70MUSD
vs all stocks (USD)
Updated Jul 19, 2026
EBITDA (TTM)
-21.48MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Net Income (TTM)
-27.79MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Quarterly Earnings Growth (YoY)
25.99%
Updated Jul 19, 2026
Operating Cash Flow (TTM)
-43.79MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Levered Free Cash Flow (TTM)
-22.95MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 19, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 19, 2026
Payout Ratio
0.00%
Updated Jul 19, 2026
Revenue
63.06MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
13.69MUSDFY2025 · Dec 31, 2025
Gross Profit
49.37MUSDFY2025 · Dec 31, 2025
Operating Income
-32.83MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-44.65MUSDFY2025 · Dec 31, 2025
Income Tax Expense
-3.44MUSDFY2025 · Dec 31, 2025
Net Income
-41.21MUSDFY2025 · Dec 31, 2025
EBIT
-43.95MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
-27.41MUSDFY2025 · Dec 31, 2025
Research & Development
29.86MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
52.34MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
1.95MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
697.00KUSDFY2025 · Dec 31, 2025
EPS (Basic)
-1.39USDFY2025 · Dec 31, 2025
EPS (Diluted)
-1.39USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
29.74MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
29.74MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-41.21MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
-6.40MUSDFY2025 · Dec 31, 2025
Free Cash Flow
-6.99MUSDDerived from operating cash flow minus capital expenditure. This filing charges 3.47M of depreciation against 586K of capital expenditure, and its own free-cash-flow line reads -34.52M.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
17.26MUSDFY2025 · Dec 31, 2025
Income Tax Paid
550.00KUSDFY2025 · Dec 31, 2025
Interest Paid
359.00KUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-41.21MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
3.47MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
10.81MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
13.16MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-379.00KUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-781.00KUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
8.52MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-586.00KUSDFY2025 · Dec 31, 2025
Net Acquisitions
-32.88MUSDFY2025 · Dec 31, 2025
Purchase of Investments
0.00USDFY2025 · Dec 31, 2025
Sale of Investments
67.19MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
33.72MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
0.00USDFY2025 · Dec 31, 2025
Net Short-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
-3.11MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-2.21MUSDFY2025 · Dec 31, 2025
Shares Outstanding
32.23MSharesUpdated Jul 19, 2026
Float Shares
13.16MSharesUpdated Jul 19, 2026
Shares Short
964.44KSharesUpdated Jul 19, 2026
Short Ratio
1.24days
vs all stocks
Updated Jul 19, 2026
Short % of Shares Outstanding
10.06%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 2.99%.Updated Jul 19, 2026
% Held by Insiders
60.61%
vs all stocks
Updated Jul 19, 2026
% Held by Institutions
23.77%
vs all stocks
Updated Jul 19, 2026
Total Cash (MRQ)
10.93MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Cash per Share (MRQ)
0.3340USDUpdated Jul 19, 2026
Total Debt (MRQ)
5.27MUSD
vs all stocks (USD)
Updated Jul 19, 2026
Total Debt to Equity (MRQ)
0.0687x
Updated Jul 19, 2026
Current Ratio (MRQ)
1.42x
Updated Jul 19, 2026
Book Value per Share (MRQ)
2.38USDUpdated Jul 19, 2026
Total Assets
122.64MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
46.08MUSDFY2025 · Dec 31, 2025
Total Liabilities
47.65MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
76.57MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
9.25MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
38.40MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
9.01MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
1.02MUSDFY2025 · Dec 31, 2025
Accounts Receivable
9.71MUSDFY2025 · Dec 31, 2025
Accounts Payable
3.48MUSDFY2025 · Dec 31, 2025
Short-term Debt
1.12MUSDFY2025 · Dec 31, 2025
Deferred Revenue
10.75MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
9.41MUSDFY2025 · Dec 31, 2025
Long-term Debt
1.96MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
2.13MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
3.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-69.22MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
74.99MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
3.07USDUpdated Jul 19, 2026
52-Week High
14.39USDUpdated Jul 19, 2026
52-Week Change
97.02%
vs all stocks
Updated Jul 19, 2026
Beta
0.3940x
vs all stocks
Updated Jul 19, 2026
50-Day MA
11.23USDUpdated Jul 19, 2026
200-Day MA
6.82USDUpdated Jul 19, 2026
Avg 10-Day Volume
443.16KSharesUpdated Jul 19, 2026
Avg 30-Day Volume
601.51KSharesUpdated Jul 19, 2026
Diluted EPS (TTM)
-0.9100USDUpdated Jul 19, 2026
Other Income / Expense
-13.07MUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.86Profit Margin: -0.42
Financial Health
Altman Z-Score 1.97: grey zoneSignificant
Altman Z-Score: 1.97
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $266.07M, lower than 95% of all stocks globallySignificant
Market cap (USD): 266,072,282Global P5: 269,387,740.27
Companies that share the same coordination system — how they create, deliver, or capture value.